Monte Rosa Therapeutics annual net debt
2021
2022
2023
2024
2025
Monte Rosa Therapeutics Net Debt Growth & History (GLUE)
Monte Rosa Therapeutics's net debt was −$90.7M for fiscal 2025.
View full Monte Rosa Therapeutics company overviewMonte Rosa Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$90.7M | $90.8M | — |
| 2024 | 2024-12-31 | −$181.5M | −$99.5M | — |
| 2023 | 2023-12-31 | −$82.1M | −$74.2M | — |
| 2022 | 2022-12-31 | −$7.9M | $338.2M | — |
| 2021 | 2021-12-31 | −$346.1M | — | — |
Monte Rosa Therapeutics quarterly net debt
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$52.1M | −$23.8M | — |
| Q1 2026 | 2026-03-31 | −$120.8M | −$84.1M | — |
| Q4 2025 | 2025-12-31 | −$90.7M | $90.8M | — |
| Q3 2025 | 2025-09-30 | −$168.2M | −$86.3M | — |
| Q2 2025 | 2025-06-30 | −$28.3M | $36.2M | — |
| Q1 2025 | 2025-03-31 | −$36.7M | $17.9M | — |
| Q4 2024 | 2024-12-31 | −$181.5M | −$99.5M | — |
| Q3 2024 | 2024-09-30 | −$81.9M | −$69.2M | — |
| Q2 2024 | 2024-06-30 | −$64.5M | −$64.5M | — |
| Q1 2024 | 2024-03-31 | −$54.6M | −$48.9M | — |
| Q4 2023 | 2023-12-31 | −$82.1M | −$74.2M | — |
| Q3 2023 | 2023-09-30 | −$12.7M | $54.1M | — |
| Q2 2023 | 2023-06-30 | $8,000 | $54.9M | — |
| Q1 2023 | 2023-03-31 | −$5.7M | $127.2M | — |
| Q4 2022 | 2022-12-31 | −$7.9M | $338.2M | — |
| Q3 2022 | 2022-09-30 | −$66.7M | — | — |
| Q2 2022 | 2022-06-30 | −$54.9M | — | — |
| Q1 2022 | 2022-03-31 | −$132.9M | — | — |
| Q4 2021 | 2021-12-31 | −$346.1M | — | — |
Monte Rosa Therapeutics net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Monte Rosa Therapeutics's net debt increased from −$346.1M to −$90.7M, a change of $255.4M. The latest reported quarter, Q2 2026, shows −$52.1M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Monte Rosa Therapeutics source filings ↗